Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
The WHO Implementation Tool for Monitoring the Toxicity of New Antiretroviral and Antiviral Medicines in HIV and Viral Hepatitis Programmes provides a framework for pharmacovigilance monitoring within the context of national treatment programs. Although this framework allows for inclusion of pregnant women, it does not include surveillance of many important maternal and child health outcomes. The surveillance tools included in this package, including a PBFP PrEP Surveillance Register and a PBFP PrEP Case Report Form are meant to serve as templates for countries to adapt to fit their own surveillance systems.
Resource Details
- Resource Category
- Implementation Resources
- Document Type
- M&E Tool
- Year
- 2023
- Population
- PBFW Focused Resource
- Source
- MOSAIC/PrEP Watch
More Resources
PrEP and PEP Guidelines-Zambia
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
HIV Prevention Ambassador Training Package and Toolkit
Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection
National Guidelines for the Management of HIV and AIDS
No results found.